In 1995, Congress banned federal funding for destructive research into human embryos — the source of the most
promising type of stem cells.
Not exact matches
The therapeutic use
of stem cells is a
promising area
of medicine for the decades ahead and researchers are examining why
stem cells function in certain
types of niches, microenvironments, and pockets
of activity.
The therapeutic
promise of stem cell research rests on using pluripotent
stem cells, which can be grown into many
of the
types of cells found in the human body.
Researchers have demonstrated that the enzymatic activity
of R5 receptor -
type protein tyrosine phosphatases is a requisite for the maintenance
of stem cell properties and tumorigenicity in glioblastoma
cells and could be a
promising drug target for treatment.
These new
types of stem cells have the capacity to turn into many other
cell types, holding immense
promise for regenerating damaged tissues all over the body.
But even before the cash spigot opens, the government may close it — or even try to limit research on human embryonic
stem cells, the more
promising and controversial
type of stem cell.
Embryonic
stem cells — «pluripotent»
cells that can develop into any
type of cell in the human body — hold tremendous
promise for regenerative medicine, in which damaged organs and tissues can be replaced or repaired.